A study for a 64 year old woman who takes Amiodarone Hydrochloride - from FDA reports


Summary

3,289 females aged 64 (±5) who take the same drug are studied. This is a personalized study for a 64 year old female patient who has Psvt. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Jul, 16, 2017

3,289 females aged 64 (±5) who take Amiodarone Hydrochloride are studied.


Number of reports submitted per year:

Amiodarone Hydrochloride for a 64-year old woman.

Information of the patient in this study:

  • Age: 64
  • Gender: female
  • Conditions: Psvt
  • Drugs taken:
    • Amiodarone Hydrochloride (amiodarone hydrochloride)

eHealthMe real world results:

Most common side effects over time

< 1 month:
  • agranulocytosis
  • renal failure acute
  • pain
  • pneumonia
  • erythema multiforme
  • interstitial nephritis
  • cholestasis
  • breathing difficulty
  • acute kidney failure
  • injury
1 - 6 months:
  • renal failure acute
  • hypokalemia
  • fainting
  • thrombocytopenia
  • hypotension
  • international normalised ratio increased
  • breathing difficulty
  • nausea
  • hyperthyroidism
  • hypothyroidism
6 - 12 months:
  • cholestasis
  • hepatitis cholestatic
  • breathing difficulty
  • atrioventricular block
  • atrioventricular block complete
  • headache
  • the flu
  • multi-organ failure
  • respiratory acidosis
  • weight increased
1 - 2 years:
  • international normalised ratio increased
  • rhabdomyolysis
  • mobility decreased
  • pain in extremity
  • weakness
  • renal impairment
  • stress and anxiety
  • blood creatinine increased
  • alanine aminotransferase increased
  • breathing difficulty
2 - 5 years:
  • joint pain
  • hyperthyroidism
  • rashes
  • visual brightness
  • thyroid diseases
  • idiopathic pulmonary fibrosis
  • photosensitivity reaction
  • liver disorder
  • ards (acute respiratory distress syndrome)
  • alanine aminotransferase increased
5 - 10 years:
  • weakness
  • fatigue
  • fainting
  • atrial tachycardia
  • pigmentation disorder
  • torsade de pointes
  • cardiac arrest
  • retinopathy
  • hyperhidrosis
  • impaired healing
10+ years:
  • breast cancer female
  • drug ineffective
  • photosensitivity reaction
  • tremor
  • coordination abnormal
  • corneal deposits
  • neuropathy peripheral
not specified:
  • weakness
  • cardiac failure congestive
  • nausea
  • breathing difficulty
  • hypotension
  • acute kidney failure
  • pain
  • renal failure acute
  • stress and anxiety
  • anaemia

Top conditions involved for these people *:

  • High Blood Pressure (294 people, 8.94%)
  • Stroke (166 people, 5.05%)
  • Diabetes (158 people, 4.80%)
  • Pain (134 people, 4.07%)
  • Cardiac Disorder (119 people, 3.62%)

Top co-used drugs for these people *:

  • Lasix (490 people, 14.90%)
  • Furosemide (375 people, 11.40%)
  • Coumadin (360 people, 10.95%)
  • Digoxin (318 people, 9.67%)
  • Aspirin (249 people, 7.57%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

What are the drugs?

What are the conditions?

Related studies: